Balchem Corporation

NasdaqGS:BCPC 주식 리포트

시가총액: US$5.2b

Balchem 경영진

경영진 기준 점검 4/4

Balchem CEO는 Ted Harris, Apr2015 에 임명되었습니다 의 임기는 11.08 년입니다. 총 연간 보상은 $7.89M, 15.2% 급여 및 84.8% 보너스(회사 주식 및 옵션 포함)로 구성됩니다. 는 $15.35M 가치에 해당하는 회사 주식의 0.29% 직접 소유합니다. 경영진과 이사회의 평균 재임 기간은 3.8 년과 8.3 년입니다.

핵심 정보

Ted Harris

최고경영자

US$7.9m

총 보수

CEO 급여 비율15.18%
CEO 재임 기간11.1yrs
CEO 지분 보유율0.3%
경영진 평균 재임 기간3.8yrs
이사회 평균 재임 기간8.3yrs

최근 경영진 업데이트

Recent updates

Balchem: An Attractive Valuation Makes This Stock A Buy

Mar 27

Long-Term Nutrition And Health Trends Will Support Stronger Margins And Earnings Potential

Catalysts About Balchem Balchem supplies specialty nutrients and ingredients for human, animal and plant health, along with performance gases and related solutions. What are the underlying business or industry changes driving this perspective?

Encapsulation Investments And International Expansion Will Shape Balanced Future For Nutrition Specialist

Catalysts About Balchem Balchem produces specialty nutrition and ingredient solutions for human, animal and plant health, along with performance gases. What are the underlying business or industry changes driving this perspective?

BCPC: Dividend Increase And Buyback Program Will Support Steady Future Returns

Analysts kept their Balchem fair value estimate broadly steady at $191, pointing to only very small tweaks in assumptions such as discount rate, long term revenue growth, profit margin and future P/E as the basis for maintaining their target level. What's in the News On December 9, 2025, Balchem Corporation's Board of Directors declared an annual dividend of $0.96 per share, payable on January 20, 2026, to stockholders of record as of December 23, 2025.

If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

Feb 15
If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

BCPC: Share Repurchases And Higher Dividend Will Support Attractive Future Returns

Analysts have maintained their fair value estimate for Balchem at US$191. They have made only minimal adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions, indicating that their overall view on the stock's valuation drivers remains essentially unchanged.

Is Now An Opportune Moment To Examine Balchem Corporation (NASDAQ:BCPC)?

Feb 01
Is Now An Opportune Moment To Examine Balchem Corporation (NASDAQ:BCPC)?

BCPC: Share Repurchases And Rising Dividend Will Support Attractive Future Returns

Analysts have maintained their Balchem fair value estimate at US$191, with only small tweaks to the discount rate, revenue growth, profit margin, and forward P/E assumptions. This reflects a largely unchanged view on the stock's risk and earnings profile.

BCPC: Share Repurchases And Dividend Increases Will Support Attractive Future Returns

Analysts kept their fair value estimate for Balchem steady at US$191, pointing to only very small model tweaks in the discount rate, revenue growth, margin and forward P/E assumptions rather than any change in their overall view of the company. What's in the News Balchem Corporation announced a share repurchase program authorizing the company to buy back up to 4,000,000 shares, with no expiration date on the program (Key Developments).

BCPC: Share Repurchases And Dividend Increases Will Drive Attractive Future Returns

Analysts have maintained their price target on Balchem at approximately $191.00. This reflects only marginal tweaks to underlying assumptions such as discount rate, revenue growth, and profit margin, rather than a material change in their outlook.

BCPC: Share Repurchases Will Support Attractive Long Term Return Potential

Analysts have lowered their price target on Balchem by approximately $9 to about $191 per share, reflecting more cautious assumptions around revenue growth and profit margins, even though long term valuation multiples are slightly higher. What's in the News Completed a long running share repurchase program, buying back a total of 3,475,622 shares, or about 12.76% of shares outstanding, for approximately $190.58 million since the authorization began in 1999 (Key Developments) During the most recent quarter from July 1, 2025 to September 30, 2025, repurchased 95,760 shares, roughly 0.3% of shares outstanding, for $15.42 million as the final tranche under the existing buyback plan (Key Developments) Valuation Changes The Fair Value Estimate has fallen modestly from about $200.33 to $191.00 per share, reflecting a slightly more conservative outlook.

Balchem (NASDAQ:BCPC) Is Experiencing Growth In Returns On Capital

Dec 01
Balchem (NASDAQ:BCPC) Is Experiencing Growth In Returns On Capital

Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio

Oct 10
Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio

Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Sep 26
Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Aug 26
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

Jul 21
Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Jun 23
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

May 26
When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

May 12
Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem's Q3 Shows Record Earnings And Valuation Pressure

Oct 28
User avatar

Innovating In Nutrition And Health Sectors Drives Strong Financial Growth And Market Expansion

Launch of Optifolin+ in the nutrition segment and strong Human Nutrition & Health sales indicate potential for market share expansion and sustained revenue growth.

Balchem: A Tale Of Two Businesses

May 10

Balchem: Potential Turnaround Is In The Price

Feb 21

CEO 보수 분석

Ted Harris의 보수는 Balchem의 수익에 비해 어떻게 변했나요?
날짜총 보수급여회사 수익
Mar 31 2026n/an/a

US$158m

Dec 31 2025US$8mUS$1m

US$155m

Sep 30 2025n/an/a

US$149m

Jun 30 2025n/an/a

US$143m

Mar 31 2025n/an/a

US$137m

Dec 31 2024US$7mUS$1m

US$128m

Sep 30 2024n/an/a

US$122m

Jun 30 2024n/an/a

US$117m

Mar 31 2024n/an/a

US$115m

Dec 31 2023US$6mUS$1m

US$109m

Sep 30 2023n/an/a

US$103m

Jun 30 2023n/an/a

US$99m

Mar 31 2023n/an/a

US$99m

Dec 31 2022US$12mUS$1m

US$105m

Sep 30 2022n/an/a

US$109m

Jun 30 2022n/an/a

US$109m

Mar 31 2022n/an/a

US$102m

Dec 31 2021US$6mUS$1m

US$96m

Sep 30 2021n/an/a

US$93m

Jun 30 2021n/an/a

US$90m

Mar 31 2021n/an/a

US$88m

Dec 31 2020US$5mUS$1m

US$85m

Sep 30 2020n/an/a

US$83m

Jun 30 2020n/an/a

US$82m

Mar 31 2020n/an/a

US$81m

Dec 31 2019US$4mUS$915k

US$80m

보상 대 시장: Ted의 총 보수(USD7.89M)는 US 시장에서 비슷한 규모 기업의 평균(USD8.55M) 수준입니다.

보상과 수익: Ted의 보상은 지난 1년 동안 회사 실적과 일치했습니다.

CEO

Ted Harris (60 yo)

11.1yrs
재임 기간
US$7,894,874
보수

Mr. Theodore Lee Harris, also known as Ted, has been the Chief Executive Officer and President at Balchem Corporation since April 28, 2015. He serves as an Independent Director of Pentair Plc since April 3...

리더십 팀

이름직위재임 기간보수지분
Theodore Harris
CEO, President & Chairman11.1yrsUS$7.89m0.29%
$ 15.4m
Carl Bengtsson
Executive VP7.3yrsUS$2.97m0.091%
$ 4.7m
Hatsuki Miyata
Executive VP3.8yrsUS$2.39m0.016%
$ 810.4k
M. Tignor
Senior VP & Chief Human Resources Officer4.3yrsUS$1.78m0.038%
$ 2.0m
Frederic Boned
Senior VP3.5yrsUS$2.25m0.012%
$ 647.9k
Erin Gilson
VP & Chief Accounting Officerless than a year데이터 없음0.0078%
$ 404.2k
Martin Reid
Senior VP & Chief Supply Chain Officer5.3yrsUS$1.49m0.025%
$ 1.3m
Job L. Gunsteren
Senior VP & GM of Specialty Products3.7yrs데이터 없음데이터 없음
George Graham
Senior VP and Chief R&D Officerless than a year데이터 없음0.010%
$ 523.4k
3.8yrs
평균 재임 기간
48.5yo
평균 나이

경험이 풍부한 관리: BCPC의 경영진은 경험이 있음으로 간주됩니다(평균 재임 3.8 년).

이사회 구성원

이름직위재임 기간보수지분
Theodore Harris
CEO, President & Chairman11.1yrsUS$7.89m0.29%
$ 15.4m
Daniel Knutson
Independent Director8.3yrsUS$251.00k0.014%
$ 733.3k
David Fischer
Independent Director15.7yrsUS$231.00k0.028%
$ 1.4m
Matthew Wineinger
Lead Independent Director10.7yrsUS$271.00k0.025%
$ 1.3m
Olivier Rigaud
Independent Director2.7yrsUS$231.00k0.0075%
$ 388.5k
Kathleen Fish
Independent Director4.9yrsUS$246.00k0.011%
$ 557.8k
Monica Vicente
Independent Director2.7yrsUS$231.00k0.0075%
$ 388.5k
8.3yrs
평균 재임 기간
61yo
평균 나이

경험이 풍부한 이사회: BCPC의 이사회는 경험이 있음으로 간주됩니다(평균 재임 8.3 년).

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/05/05 12:19
종가2026/05/05 00:00
수익2026/03/31
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Balchem Corporation는 9명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Robert LabickCJS Securities, Inc.
Timothy RameyD.A. Davidson & Co.
Raghuram SelvarajuH.C. Wainwright & Co.